Vatalanib 2HCl
| CAS No. | 212141-51-0 | Cat. No. | BCP27632 |
| Name | Vatalanib 2HCl | ||
| Synonyms | CGP-79787D;CGP79787D;CGP 79787D;CGP-79787;CGP79787;ZK-222584;ZK 222584;ZK222584;PTK-787;PTK 787;PTK787; ZK-232934; CGP79787D; PTK787/ZK 222584; CGP-7978; | ||
| Formula | C20H15ClN4 | M. Wt | 419.73 |
| Description | Vatalanib, also known as PTK787, is an orally bioavailable anilinophthalazine with potential antineoplastic activity. Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis. This agent also binds to and inhibits related receptor tyrosine kinases, including platelet-derived growth factor (PDGF) receptor, c-Kit, and c-Fms. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | VEGFR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.